Your browser doesn't support javascript.
loading
A Non-severe Coronavirus Disease 2019 Patient With Persistently High Interleukin-6 Level.
Hambali, Nurfarah Lydia; Mohd Noh, Malehah; Paramasivam, Shahleni; Chua, Tock Hing; Hayati, Firdaus; Payus, Alvin Oliver; Tee, Tze Yuan; Rosli, Khairul Taufiq; Abd Rachman Isnadi, Mohammad Faruq; Manin, Benny O.
Afiliación
  • Hambali NL; Department of Pathobiology and Medical Diagnostic, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia.
  • Mohd Noh M; Medical Based Department, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia.
  • Paramasivam S; Medical Based Department, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia.
  • Chua TH; Department of Pathobiology and Medical Diagnostic, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia.
  • Hayati F; Surgical Based Department, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia.
  • Payus AO; Medical Based Department, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia.
  • Tee TY; Medical Department, Tawau Hospital, Tawau, Malaysia.
  • Rosli KT; Medical Department, Tawau Hospital, Tawau, Malaysia.
  • Abd Rachman Isnadi MF; Department of Pathobiology and Medical Diagnostic, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia.
  • Manin BO; Department of Pathobiology and Medical Diagnostic, Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kota Kinabalu, Malaysia.
Front Public Health ; 8: 584552, 2020.
Article en En | MEDLINE | ID: mdl-33304877
Interleukin 6 (IL-6) is one of the markers of immune system activation indicating existent infection and inflammation. We present here a case of a 55-year-old male COVID-19 patient with an unusual high level of interleukin 6 (IL-6). Further investigation revealed he had hepatocellular carcinoma (HCC) with underlying hepatitis B. He did not present with respiratory symptoms although a baseline chest x-ray showed changes, and the patient was categorized as Class 3A of COVID-19. Routine investigations proceeded with high-resolution computed tomography and IL-6 to monitor for progression to severe COVID-19. Notably, there was a high IL-6 level but other parameters did not show he was in severe COVID-19. In this report, we conclude that elevated IL-6 level in a COVID-19 patient is not necessarily associated with severe COVID-19.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interleucina-6 / COVID-19 Límite: Humans / Male / Middle aged Idioma: En Revista: Front Public Health Año: 2020 Tipo del documento: Article País de afiliación: Malasia Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Interleucina-6 / COVID-19 Límite: Humans / Male / Middle aged Idioma: En Revista: Front Public Health Año: 2020 Tipo del documento: Article País de afiliación: Malasia Pais de publicación: Suiza